Valsartan
Valsartan is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Valsartan; Generic name: VALSARTAN; Drug class: Angiotensin 2 Receptor Blocker [EPC].
| Brand name | Valsartan |
|---|---|
| Generic name | VALSARTAN |
| Drug class | Angiotensin 2 Receptor Blocker [EPC] |
| Manufacturer | Northwind Health Company, LLC |
| Used for | 1 INDICATIONS AND USAGE Valsartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Hypertension, to lower blood pressure in adults and children 1 year and older. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions ( 1.1 ) Heart failure (NYHA class II-IV), to reduce hospitalization for heart failure in adults ( 1.2 ) Post-myocardial infarction , for the reduction of cardiovascular mortality in clinically stable patients with left ventricular failure or left ventricular dysfunction following myocardial infarction in adults ( 1.3 ) 1.1 Hypertension Valsartan tablets are indicated for the treatment |
| Dosage | 2 DOSAGE AND ADMINISTRATION Indication Starting Dose Dose Range * Hypertension Adult ( 2.2 ) 80-160 mg once daily 80-320 mg once daily 1-16 years ( 2.3 ) 1 mg/kg once daily Up to 40 mg daily 1-4 mg/kg once daily Up to 160 mg daily Heart Failure ( 2.4 ) 40 mg twice daily 40-160 mg twice daily Post-Myocardial Infarction ( 2.5 ) 20 mg twice daily 20-160 mg twice daily * As tolerated by patient 2.1 Important Dosage and Preparation Information Valsartan tablets and oral suspension are not substitutab |
| Warnings | WARNING: FETAL TOXICITY When pregnancy is detected, discontinue valsartan as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. ( 5.1 ) WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue valsartan as soon as possible. ( 5.1 ) Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus. ( 5.1 ) |
| Active ingredient(s) | VALSARTAN |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03af7d09-314a-fe85-e063-6294a90afa25 |